Indianapolis, IN, United States of America

Patrick J Loehrer

This inventor holds 1 USPTO granted patent. Top assignees: Castle Biosciences, Incorporated, Indiana University. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Patrick J Loehrer

Introduction

Patrick J Loehrer is a notable inventor based in Indianapolis, IN, who has made significant contributions to the field of cancer diagnostics. He holds a patent that focuses on the detection, diagnosis, and prognosis of thymic cancer, showcasing his commitment to advancing medical technology.

Latest Patents

Loehrer's patent, titled "Compositions for and methods of detecting, diagnosing, and prognosing thymic cancer," provides essential biomarkers for identifying thymic cancer in individuals. This innovation includes kits designed to measure the expression levels or presence of these biomarkers, facilitating early detection and diagnosis. The methods outlined in the patent are crucial for individuals suspected of having thymic cancer, offering a pathway for timely medical intervention.

Career Highlights

Throughout his career, Patrick J Loehrer has worked with esteemed institutions such as Indiana University and Castle Biosciences, Incorporated. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his contributions to cancer research and diagnostics.

Collaborations

Some of his notable coworkers include Sunil Badve and Yesim Gokmen-Polar, who have played significant roles in his research endeavors. Their collaboration has likely enriched the development of innovative solutions in cancer diagnostics.

Conclusion

Patrick J Loehrer's work exemplifies the impact of innovation in the medical field, particularly in cancer detection and diagnosis. His patent represents a significant advancement that could improve outcomes for patients with thymic cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…